Clover Health Reports Strong Q1 2026 Earnings with 51% Membership Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3 days ago
0mins
Should l Buy CLOV?
Source: seekingalpha
- Significant Membership Growth: Clover Health achieved a 51% year-over-year increase in membership in Q1 2026, reaching approximately 156,000 members, which drove total revenues to $749 million, up 62%, showcasing its strong growth potential in the Medicare market.
- Improved Profitability: The company reported a GAAP net income of $27 million in the first quarter, reflecting ongoing improvements in profitability while maintaining market-leading growth, indicating the sustainability of its business model.
- Operational Efficiency Optimization: The insurance loss ratio for the quarter was 86.5%, while adjusted SG&A expenses were $119 million, or 16% of revenue, improving by approximately 200 basis points year-over-year, demonstrating positive progress in cost control and operational efficiency.
- Optimistic Future Outlook: Management expects to achieve full-year GAAP net income profitability in 2026 and to exceed expectations across all metrics, although they emphasize a cautious approach until more complete data is available to ensure robust business development.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CLOV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CLOV
Wall Street analysts forecast CLOV stock price to rise
2 Analyst Rating
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 2.820
Low
3.00
Averages
3.35
High
3.70
Current: 2.820
Low
3.00
Averages
3.35
High
3.70
About CLOV
Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Clover Health Reports Strong Q1 2026 Earnings with 51% Membership Growth
- Significant Membership Growth: Clover Health achieved a 51% year-over-year increase in membership in Q1 2026, reaching approximately 156,000 members, which drove total revenues to $749 million, up 62%, showcasing its strong growth potential in the Medicare market.
- Improved Profitability: The company reported a GAAP net income of $27 million in the first quarter, reflecting ongoing improvements in profitability while maintaining market-leading growth, indicating the sustainability of its business model.
- Operational Efficiency Optimization: The insurance loss ratio for the quarter was 86.5%, while adjusted SG&A expenses were $119 million, or 16% of revenue, improving by approximately 200 basis points year-over-year, demonstrating positive progress in cost control and operational efficiency.
- Optimistic Future Outlook: Management expects to achieve full-year GAAP net income profitability in 2026 and to exceed expectations across all metrics, although they emphasize a cautious approach until more complete data is available to ensure robust business development.
See More
Surprise Increase in Medicare Advantage Payment Rates Boosts Healthcare Stocks
- Medicare Payment Rate Increase: The government unexpectedly raised payment rates for Medicare Advantage plans, increasing the federal funds received per patient by insurance companies, which is projected to enhance profit margins for major providers like UnitedHealth and Humana.
- Alignment Healthcare Stock Surge: Alignment Healthcare (NASDAQ:ALHC) shares jumped 18.7%, reflecting a strong market reaction to the company's outlook, with 26 moves greater than 5% in the past year indicating significant market perception shifts due to this news.
- Market Rally: The increase in Medicare payment rates boosted overall market confidence, leading to significant gains in major indices like the S&P 500 and Dow Jones Industrial Average, which in turn spurred widespread buying activity in major healthcare stocks.
- Investment Return Analysis: Alignment Healthcare has risen 9.3% since the beginning of the year, trading at $22.11, close to its 52-week high of $23.81 from January 2026, with a five-year investment of $1,000 now worth $1,016, demonstrating its long-term investment value.
See More
Clover Health Partners with HealthEx to Enhance Healthcare Data Interoperability
- Data Interoperability Partnership: Clover Health's new collaboration with HealthEx enables Medicare Advantage members to securely access and share clinical records and claims data, further advancing patients' rights to their health data, which is central to federal interoperability efforts.
- Streamlined User Experience: Through HealthEx, Clover members can verify their identity and authorize access to their records, simplifying the process of retrieving clinical records and claims data, thus enhancing user experience and satisfaction by eliminating the need for multiple portal logins.
- Infrastructure Expansion: This collaboration builds on the interoperability infrastructure powered by Counterpart Health, which not only supports Clover Health's data exchange but also provides scalable interoperability capabilities for other health plans, fostering collaboration across the healthcare ecosystem.
- Patient-Directed Health Management: Clover Health empowers members to access their health records more comprehensively through this functionality, granting patients control over their health information and demonstrating how member-directed access can be implemented in practice.
See More
Surge in Options Trading Volume for Enovix and Clover Health
- Enovix Options Volume: Enovix Corp saw options trading volume of 47,349 contracts, equivalent to approximately 4.7 million shares, representing about 85% of its average daily trading volume of 5.6 million shares over the past month, indicating heightened market interest in its future performance.
- High-Frequency Trading: Notably, the $7 strike call option expiring on October 16, 2026, has seen 11,736 contracts traded today, representing around 1.2 million underlying shares, suggesting increased investor expectations for Enovix's stock price appreciation.
- Clover Options Activity: Clover Health Investments Corp recorded options trading volume of 45,122 contracts, approximately 4.5 million shares, which accounts for about 80% of its average daily trading volume of 5.6 million shares over the past month, reflecting active market interest in its stock.
- Clover High-Frequency Trading: The $2 strike call option expiring on April 10, 2026, has seen 13,076 contracts traded today, representing about 1.3 million underlying shares, indicating optimistic sentiment among investors regarding Clover's future performance.
See More
Advertising Stocks Surge, Led by Advantage Solutions
- Advertising Sector Uptrend: Advertising stocks collectively rose by approximately 2.5% on Monday, indicating a renewed market confidence in the sector, which may reflect expectations of increased advertising spending and subsequently boost related companies' performance.
- Advantage Solutions Leads: Advantage Solutions saw its stock price surge by about 9.7%, positioning it as the leader among advertising stocks, suggesting investor optimism regarding its future growth potential, possibly linked to recent business expansions or new client acquisition strategies.
- National CineMedia Strong Performance: National CineMedia's stock increased by approximately 6.5%, reflecting market confidence in its cinema advertising segment, likely benefiting from the recovery of the film industry and the return of audiences to theaters, which could enhance advertising revenues.
- Positive Industry Outlook: The robust performance of advertising stocks may signal overall economic recovery, with investors maintaining an optimistic view on increased advertising expenditures, which will likely enhance the profitability and market valuations of related companies.
See More
Clover Health CFO Resignation and Interim Appointment Announced
- Executive Change: Clover Health announced that CFO Peter Kuipers will resign effective March 30, 2026, while remaining in an advisory role until April 24, 2026, to ensure a smooth transition in financial management.
- Interim Appointment: The Board has appointed Clay Thornton, the current CFO of Clover’s insurance plan, as interim CFO effective immediately, aimed at maintaining financial stability during the executive transition.
- Market Reaction: Clover Health's stock rose 1.136% in premarket trading to $1.78, reflecting investor confidence in the company's future despite potential short-term uncertainties associated with the executive change.
- Future Outlook: Clover Health expects a 46% membership growth and its first full year of GAAP profitability in 2026, indicating positive progress in improving financial performance and market positioning.
See More
Clover Health Reports Strong Q1 2026 Earnings with 51% Membership Growth
- Significant Membership Growth: Clover Health achieved a 51% year-over-year increase in membership in Q1 2026, reaching approximately 156,000 members, which drove total revenues to $749 million, up 62%, showcasing its strong growth potential in the Medicare market.
- Improved Profitability: The company reported a GAAP net income of $27 million in the first quarter, reflecting ongoing improvements in profitability while maintaining market-leading growth, indicating the sustainability of its business model.
- Operational Efficiency Optimization: The insurance loss ratio for the quarter was 86.5%, while adjusted SG&A expenses were $119 million, or 16% of revenue, improving by approximately 200 basis points year-over-year, demonstrating positive progress in cost control and operational efficiency.
- Optimistic Future Outlook: Management expects to achieve full-year GAAP net income profitability in 2026 and to exceed expectations across all metrics, although they emphasize a cautious approach until more complete data is available to ensure robust business development.
See More
Surprise Increase in Medicare Advantage Payment Rates Boosts Healthcare Stocks
- Medicare Payment Rate Increase: The government unexpectedly raised payment rates for Medicare Advantage plans, increasing the federal funds received per patient by insurance companies, which is projected to enhance profit margins for major providers like UnitedHealth and Humana.
- Alignment Healthcare Stock Surge: Alignment Healthcare (NASDAQ:ALHC) shares jumped 18.7%, reflecting a strong market reaction to the company's outlook, with 26 moves greater than 5% in the past year indicating significant market perception shifts due to this news.
- Market Rally: The increase in Medicare payment rates boosted overall market confidence, leading to significant gains in major indices like the S&P 500 and Dow Jones Industrial Average, which in turn spurred widespread buying activity in major healthcare stocks.
- Investment Return Analysis: Alignment Healthcare has risen 9.3% since the beginning of the year, trading at $22.11, close to its 52-week high of $23.81 from January 2026, with a five-year investment of $1,000 now worth $1,016, demonstrating its long-term investment value.
See More
Clover Health Partners with HealthEx to Enhance Healthcare Data Interoperability
- Data Interoperability Partnership: Clover Health's new collaboration with HealthEx enables Medicare Advantage members to securely access and share clinical records and claims data, further advancing patients' rights to their health data, which is central to federal interoperability efforts.
- Streamlined User Experience: Through HealthEx, Clover members can verify their identity and authorize access to their records, simplifying the process of retrieving clinical records and claims data, thus enhancing user experience and satisfaction by eliminating the need for multiple portal logins.
- Infrastructure Expansion: This collaboration builds on the interoperability infrastructure powered by Counterpart Health, which not only supports Clover Health's data exchange but also provides scalable interoperability capabilities for other health plans, fostering collaboration across the healthcare ecosystem.
- Patient-Directed Health Management: Clover Health empowers members to access their health records more comprehensively through this functionality, granting patients control over their health information and demonstrating how member-directed access can be implemented in practice.
See More
Surge in Options Trading Volume for Enovix and Clover Health
- Enovix Options Volume: Enovix Corp saw options trading volume of 47,349 contracts, equivalent to approximately 4.7 million shares, representing about 85% of its average daily trading volume of 5.6 million shares over the past month, indicating heightened market interest in its future performance.
- High-Frequency Trading: Notably, the $7 strike call option expiring on October 16, 2026, has seen 11,736 contracts traded today, representing around 1.2 million underlying shares, suggesting increased investor expectations for Enovix's stock price appreciation.
- Clover Options Activity: Clover Health Investments Corp recorded options trading volume of 45,122 contracts, approximately 4.5 million shares, which accounts for about 80% of its average daily trading volume of 5.6 million shares over the past month, reflecting active market interest in its stock.
- Clover High-Frequency Trading: The $2 strike call option expiring on April 10, 2026, has seen 13,076 contracts traded today, representing about 1.3 million underlying shares, indicating optimistic sentiment among investors regarding Clover's future performance.
See More
Advertising Stocks Surge, Led by Advantage Solutions
- Advertising Sector Uptrend: Advertising stocks collectively rose by approximately 2.5% on Monday, indicating a renewed market confidence in the sector, which may reflect expectations of increased advertising spending and subsequently boost related companies' performance.
- Advantage Solutions Leads: Advantage Solutions saw its stock price surge by about 9.7%, positioning it as the leader among advertising stocks, suggesting investor optimism regarding its future growth potential, possibly linked to recent business expansions or new client acquisition strategies.
- National CineMedia Strong Performance: National CineMedia's stock increased by approximately 6.5%, reflecting market confidence in its cinema advertising segment, likely benefiting from the recovery of the film industry and the return of audiences to theaters, which could enhance advertising revenues.
- Positive Industry Outlook: The robust performance of advertising stocks may signal overall economic recovery, with investors maintaining an optimistic view on increased advertising expenditures, which will likely enhance the profitability and market valuations of related companies.
See More
Clover Health CFO Resignation and Interim Appointment Announced
- Executive Change: Clover Health announced that CFO Peter Kuipers will resign effective March 30, 2026, while remaining in an advisory role until April 24, 2026, to ensure a smooth transition in financial management.
- Interim Appointment: The Board has appointed Clay Thornton, the current CFO of Clover’s insurance plan, as interim CFO effective immediately, aimed at maintaining financial stability during the executive transition.
- Market Reaction: Clover Health's stock rose 1.136% in premarket trading to $1.78, reflecting investor confidence in the company's future despite potential short-term uncertainties associated with the executive change.
- Future Outlook: Clover Health expects a 46% membership growth and its first full year of GAAP profitability in 2026, indicating positive progress in improving financial performance and market positioning.
See More
